Showing results (11-20 of 514) with videos related to
Sort By:
Pageof 52
Therapeutic Advances in Cardiovascular Disease|January 7, 2009
Pre-eclampsia: the pivotal role of the placenta in its pathophysiology and markers for early detectionAmret Hawfield, Barry I FreedmanAmerican Journal of Nephrology|August 29, 2019
Mechanisms of Stroke in Patients with Chronic Kidney DiseaseShivani Ghoshal, Barry I FreedmanCurrent Hypertension Reports|November 10, 2011
Target organ damage in African American hypertension: role of APOL1Barry I Freedman, Mariana MureaCurrent Opinion in Nephrology and Hypertension|January 7, 2010
Essential hypertension and risk of nephropathy: a reappraisalMariana Murea, Barry I FreedmanKidney Research and Clinical Practice|June 16, 2026
Kidney disease in patients with two APOL1 risk variantsBarry I Freedman, Lijun MaCurrent Diabetes Reports|May 11, 2012
Insights into the genetic architecture of diabetic nephropathyNicholette D Palmer, Barry I FreedmanKidney International|June 22, 2021
APOL1-associated kidney disease in northern Nigerians with treated HIV infectionOpeyemi A Olabisi, Barry I FreedmanExpert Review of Cardiovascular Therapy|April 2, 2011
Effects of race on albuminuria and risk of cardiovascular and kidney diseaseVardaman M Buckalew, Barry I FreedmanAdvances in Chronic Kidney Disease|April 27, 2019
The Impact of APOL1 on Chronic Kidney Disease and HypertensionTodd W Robinson, Barry I FreedmanKidney International|August 31, 2013
Genotypic variation and outcomes in kidney transplantation: donor and recipient effectsMichael D Gautreaux, Barry I FreedmanPageof 52